Molecular Evidence for Plasmodium falciparum Resistance to Sulfadoxine–Pyrimethamine but Absence of K13 Mutations in Mangaluru, Southwestern India

In most of India, sulfadoxine–pyrimethamine (SP) plus artesunate serves as first-line treatment for uncomplicated falciparum malaria. In 112 clinical Plasmodium falciparum isolates from Mangaluru, southwestern India, we sequenced molecular markers associated with resistance to SP, lumefantrine, and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Trop Med Hyg
Autors principals: Wedam, Jakob, Tacoli, Costanza, Gai, Prabhanjan P., Siegert, Konrad, Kulkarni, Suyamindra S., Rasalkar, Rashmi, Boloor, Archith, Jain, Animesh, Mahabala, Chakrapani, Baliga, Shantaram, Shenoy, Damodara, Devi, Rajeshwari, Gai, Pramod, Mockenhaupt, Frank P.
Format: Artigo
Idioma:Inglês
Publicat: The American Society of Tropical Medicine and Hygiene 2018
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6283483/
https://ncbi.nlm.nih.gov/pubmed/30398146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.18-0549
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars